Titre : Sulfonamides

Sulfonamides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Child Development

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection nécessitant des sulfonamides ?

Un diagnostic repose sur des symptômes cliniques et des cultures bactériennes.
Infections bactériennes Diagnostic médical
#2

Quels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?

Des tests de sensibilité aux antibiotiques sont réalisés sur des échantillons microbiologiques.
Sensibilité aux antibiotiques Tests de laboratoire
#3

Les sulfonamides sont-ils efficaces contre toutes les bactéries ?

Non, leur efficacité varie selon le type de bactérie et leur résistance.
Résistance bactérienne Antibiotiques
#4

Quels signes cliniques indiquent une infection bactérienne ?

Fièvre, douleur, rougeur et gonflement peuvent indiquer une infection.
Symptômes Infections bactériennes
#5

Comment confirmer une infection urinaire ?

Un examen d'urine et une culture permettent de confirmer une infection urinaire.
Infection urinaire Culture bactérienne

Symptômes 5

#1

Quels sont les symptômes d'une infection traitée par sulfonamides ?

Fièvre, douleur, fatigue et symptômes locaux selon l'infection.
Symptômes Infections bactériennes
#2

Les sulfonamides provoquent-ils des effets secondaires ?

Oui, des effets comme éruptions cutanées, nausées ou réactions allergiques peuvent survenir.
Effets secondaires Réactions allergiques
#3

Comment reconnaître une réaction allergique aux sulfonamides ?

Éruptions cutanées, démangeaisons, ou gonflement peuvent indiquer une allergie.
Allergies médicamenteuses Eruptions cutanées
#4

Quels symptômes indiquent une surinfection ?

Augmentation de la douleur, fièvre persistante et écoulement purulent peuvent indiquer une surinfection.
Surinfection Symptômes
#5

Les sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?

Oui, des nausées, vomissements ou diarrhées peuvent survenir avec leur utilisation.
Troubles gastro-intestinaux Effets secondaires

Prévention 5

#1

Comment prévenir les infections nécessitant des sulfonamides ?

Maintenir une bonne hygiène, se faire vacciner et éviter les contacts avec des malades.
Prévention des infections Hygiène
#2

Les sulfonamides peuvent-ils être utilisés en prophylaxie ?

Oui, ils peuvent être prescrits en prophylaxie pour prévenir certaines infections.
Prophylaxie Antibiotiques
#3

Quelles mesures d'hygiène sont recommandées ?

Se laver les mains régulièrement et éviter le partage d'objets personnels.
Hygiène Prévention des infections
#4

Les vaccinations aident-elles à prévenir les infections ?

Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes.
Vaccination Prévention des infections
#5

Comment éviter la résistance aux antibiotiques ?

Utiliser les antibiotiques uniquement lorsque prescrit et suivre les recommandations médicales.
Résistance aux antibiotiques Utilisation des médicaments

Traitements 5

#1

Comment les sulfonamides sont-ils administrés ?

Ils sont généralement administrés par voie orale ou intraveineuse selon l'infection.
Administration médicamenteuse Antibiotiques
#2

Quelle est la posologie habituelle des sulfonamides ?

La posologie varie selon l'infection, mais doit être prescrite par un médecin.
Posologie Antibiotiques
#3

Les sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?

Oui, ils peuvent être utilisés en association pour élargir le spectre d'action.
Thérapie combinée Antibiotiques
#4

Quel suivi est nécessaire lors d'un traitement par sulfonamides ?

Un suivi régulier pour surveiller les effets secondaires et l'efficacité est recommandé.
Suivi médical Effets secondaires
#5

Les sulfonamides sont-ils efficaces contre les infections virales ?

Non, les sulfonamides ne sont pas efficaces contre les infections virales.
Infections virales Antibiotiques

Complications 5

#1

Quelles complications peuvent survenir avec les sulfonamides ?

Des réactions allergiques graves, des troubles sanguins ou des lésions hépatiques peuvent survenir.
Complications Effets secondaires
#2

Comment gérer une réaction allergique sévère aux sulfonamides ?

Cesser immédiatement le traitement et consulter un médecin pour un traitement approprié.
Réactions allergiques Urgences médicales
#3

Les sulfonamides peuvent-ils causer des troubles rénaux ?

Oui, des troubles rénaux peuvent survenir, nécessitant une surveillance de la fonction rénale.
Troubles rénaux Effets secondaires
#4

Quels signes indiquent une complication grave ?

Fièvre élevée, éruption cutanée étendue ou difficulté respiratoire peuvent indiquer une complication.
Complications Symptômes
#5

Les sulfonamides peuvent-ils interagir avec d'autres médicaments ?

Oui, ils peuvent interagir avec d'autres médicaments, augmentant le risque d'effets secondaires.
Interactions médicamenteuses Effets secondaires

Facteurs de risque 5

#1

Qui est à risque de développer des effets secondaires aux sulfonamides ?

Les personnes ayant des antécédents d'allergies médicamenteuses sont à risque accru.
Facteurs de risque Allergies médicamenteuses
#2

Les personnes âgées sont-elles plus à risque avec les sulfonamides ?

Oui, les personnes âgées peuvent avoir un risque accru d'effets secondaires et de complications.
Personnes âgées Effets secondaires
#3

Les femmes enceintes peuvent-elles prendre des sulfonamides ?

L'utilisation doit être évitée, car elle peut affecter le fœtus. Consultez un médecin.
Grossesse Antibiotiques
#4

Les patients atteints de maladies hépatiques sont-ils à risque ?

Oui, ils peuvent avoir un risque accru d'effets indésirables et nécessitent une surveillance.
Maladies hépatiques Effets secondaires
#5

Les antécédents d'infections récurrentes augmentent-ils le risque ?

Oui, les antécédents d'infections récurrentes peuvent nécessiter un traitement plus agressif.
Infections récurrentes Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sulfonamides : Questions médicales les plus fréquentes", "headline": "Sulfonamides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sulfonamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-25", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sulfonamides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sulfones", "url": "https://questionsmedicales.fr/mesh/D013450", "about": { "@type": "MedicalCondition", "name": "Sulfones", "code": { "@type": "MedicalCode", "code": "D013450", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Bumétanide", "alternateName": "Bumetanide", "url": "https://questionsmedicales.fr/mesh/D002034", "about": { "@type": "MedicalCondition", "name": "Bumétanide", "code": { "@type": "MedicalCode", "code": "D002034", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.150" } } }, { "@type": "MedicalWebPage", "name": "Diclofénamide", "alternateName": "Dichlorphenamide", "url": "https://questionsmedicales.fr/mesh/D004005", "about": { "@type": "MedicalCondition", "name": "Diclofénamide", "code": { "@type": "MedicalCode", "code": "D004005", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.410" } } }, { "@type": "MedicalWebPage", "name": "Mafénide", "alternateName": "Mafenide", "url": "https://questionsmedicales.fr/mesh/D008272", "about": { "@type": "MedicalCondition", "name": "Mafénide", "code": { "@type": "MedicalCode", "code": "D008272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.570" } } }, { "@type": "MedicalWebPage", "name": "Méfruside", "alternateName": "Mefruside", "url": "https://questionsmedicales.fr/mesh/D008529", "about": { "@type": "MedicalCondition", "name": "Méfruside", "code": { "@type": "MedicalCode", "code": "D008529", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.575" } } }, { "@type": "MedicalWebPage", "name": "Probénécide", "alternateName": "Probenecid", "url": "https://questionsmedicales.fr/mesh/D011339", "about": { "@type": "MedicalCondition", "name": "Probénécide", "code": { "@type": "MedicalCode", "code": "D011339", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.625" } } }, { "@type": "MedicalWebPage", "name": "Sulfamides", "alternateName": "Sulfanilamides", "url": "https://questionsmedicales.fr/mesh/D013424", "about": { "@type": "MedicalCondition", "name": "Sulfamides", "code": { "@type": "MedicalCode", "code": "D013424", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Furosémide", "alternateName": "Furosemide", "url": "https://questionsmedicales.fr/mesh/D005665", "about": { "@type": "MedicalCondition", "name": "Furosémide", "code": { "@type": "MedicalCode", "code": "D005665", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.300" } } }, { "@type": "MedicalWebPage", "name": "Sulfacétamide", "alternateName": "Sulfacetamide", "url": "https://questionsmedicales.fr/mesh/D013409", "about": { "@type": "MedicalCondition", "name": "Sulfacétamide", "code": { "@type": "MedicalCode", "code": "D013409", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.650" } } }, { "@type": "MedicalWebPage", "name": "Sulfachlorpyridazine", "alternateName": "Sulfachlorpyridazine", "url": "https://questionsmedicales.fr/mesh/D013410", "about": { "@type": "MedicalCondition", "name": "Sulfachlorpyridazine", "code": { "@type": "MedicalCode", "code": "D013410", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.700" } } }, { "@type": "MedicalWebPage", "name": "Sulfadiazine", "alternateName": "Sulfadiazine", "url": "https://questionsmedicales.fr/mesh/D013411", "about": { "@type": "MedicalCondition", "name": "Sulfadiazine", "code": { "@type": "MedicalCode", "code": "D013411", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.755" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sulfadiazine d'argent", "alternateName": "Silver Sulfadiazine", "url": "https://questionsmedicales.fr/mesh/D012837", "about": { "@type": "MedicalCondition", "name": "Sulfadiazine d'argent", "code": { "@type": "MedicalCode", "code": "D012837", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.755.800" } } } ] }, { "@type": "MedicalWebPage", "name": "Sulfadiazine d'argent", "alternateName": "Silver Sulfadiazine", "url": "https://questionsmedicales.fr/mesh/D012837", "about": { "@type": "MedicalCondition", "name": "Sulfadiazine d'argent", "code": { "@type": "MedicalCode", "code": "D012837", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.755.800" } } }, { "@type": "MedicalWebPage", "name": "Sulfadiméthoxine", "alternateName": "Sulfadimethoxine", "url": "https://questionsmedicales.fr/mesh/D013412", "about": { "@type": "MedicalCondition", "name": "Sulfadiméthoxine", "code": { "@type": "MedicalCode", "code": "D013412", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.760" } } }, { "@type": "MedicalWebPage", "name": "Sulfadoxine", "alternateName": "Sulfadoxine", "url": "https://questionsmedicales.fr/mesh/D013413", "about": { "@type": "MedicalCondition", "name": "Sulfadoxine", "code": { "@type": "MedicalCode", "code": "D013413", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.765" } } }, { "@type": "MedicalWebPage", "name": "Sulfaguanidine", "alternateName": "Sulfaguanidine", "url": "https://questionsmedicales.fr/mesh/D013414", "about": { "@type": "MedicalCondition", "name": "Sulfaguanidine", "code": { "@type": "MedicalCode", "code": "D013414", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.810" } } }, { "@type": "MedicalWebPage", "name": "Sulfalène", "alternateName": "Sulfalene", "url": "https://questionsmedicales.fr/mesh/D013415", "about": { "@type": "MedicalCondition", "name": "Sulfalène", "code": { "@type": "MedicalCode", "code": "D013415", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.850" } } }, { "@type": "MedicalWebPage", "name": "Sulfamérazine", "alternateName": "Sulfamerazine", "url": "https://questionsmedicales.fr/mesh/D013416", "about": { "@type": "MedicalCondition", "name": "Sulfamérazine", "code": { "@type": "MedicalCode", "code": "D013416", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.853" } } }, { "@type": "MedicalWebPage", "name": "Sulfamétoxydiazine", "alternateName": "Sulfameter", "url": "https://questionsmedicales.fr/mesh/D013417", "about": { "@type": "MedicalCondition", "name": "Sulfamétoxydiazine", "code": { "@type": "MedicalCode", "code": "D013417", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.857" } } }, { "@type": "MedicalWebPage", "name": "Sulfadimidine", "alternateName": "Sulfamethazine", "url": "https://questionsmedicales.fr/mesh/D013418", "about": { "@type": "MedicalCondition", "name": "Sulfadimidine", "code": { "@type": "MedicalCode", "code": "D013418", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.862" } } }, { "@type": "MedicalWebPage", "name": "Sulfaméthoxazole", "alternateName": "Sulfamethoxazole", "url": "https://questionsmedicales.fr/mesh/D013420", "about": { "@type": "MedicalCondition", "name": "Sulfaméthoxazole", "code": { "@type": "MedicalCode", "code": "D013420", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.867" } } }, { "@type": "MedicalWebPage", "name": "Sulfaméthoxypyridazine", "alternateName": "Sulfamethoxypyridazine", "url": "https://questionsmedicales.fr/mesh/D013421", "about": { "@type": "MedicalCondition", "name": "Sulfaméthoxypyridazine", "code": { "@type": "MedicalCode", "code": "D013421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.872" } } }, { "@type": "MedicalWebPage", "name": "Sulfamonométhoxine", "alternateName": "Sulfamonomethoxine", "url": "https://questionsmedicales.fr/mesh/D013422", "about": { "@type": "MedicalCondition", "name": "Sulfamonométhoxine", "code": { "@type": "MedicalCode", "code": "D013422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.877" } } }, { "@type": "MedicalWebPage", "name": "Sulfamoxole", "alternateName": "Sulfamoxole", "url": "https://questionsmedicales.fr/mesh/D013423", "about": { "@type": "MedicalCondition", "name": "Sulfamoxole", "code": { "@type": "MedicalCode", "code": "D013423", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.882" } } }, { "@type": "MedicalWebPage", "name": "Sulfanilamide", "alternateName": "Sulfanilamide", "url": "https://questionsmedicales.fr/mesh/D000077145", "about": { "@type": "MedicalCondition", "name": "Sulfanilamide", "code": { "@type": "MedicalCode", "code": "D000077145", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.885" } } }, { "@type": "MedicalWebPage", "name": "Sulfapyridine", "alternateName": "Sulfapyridine", "url": "https://questionsmedicales.fr/mesh/D013427", "about": { "@type": "MedicalCondition", "name": "Sulfapyridine", "code": { "@type": "MedicalCode", "code": "D013427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.900" } } }, { "@type": "MedicalWebPage", "name": "Sulfaquinoxaline", "alternateName": "Sulfaquinoxaline", "url": "https://questionsmedicales.fr/mesh/D013428", "about": { "@type": "MedicalCondition", "name": "Sulfaquinoxaline", "code": { "@type": "MedicalCode", "code": "D013428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.925" } } }, { "@type": "MedicalWebPage", "name": "Sulfaméthizol", "alternateName": "Sulfamethizole", "url": "https://questionsmedicales.fr/mesh/D013419", "about": { "@type": "MedicalCondition", "name": "Sulfaméthizol", "code": { "@type": "MedicalCode", "code": "D013419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.935.813" } } }, { "@type": "MedicalWebPage", "name": "Sulfisomidine", "alternateName": "Sulfisomidine", "url": "https://questionsmedicales.fr/mesh/D013443", "about": { "@type": "MedicalCondition", "name": "Sulfisomidine", "code": { "@type": "MedicalCode", "code": "D013443", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.940" } } }, { "@type": "MedicalWebPage", "name": "Sulfafurazol", "alternateName": "Sulfisoxazole", "url": "https://questionsmedicales.fr/mesh/D013444", "about": { "@type": "MedicalCondition", "name": "Sulfafurazol", "code": { "@type": "MedicalCode", "code": "D013444", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.725.945" } } } ] }, { "@type": "MedicalWebPage", "name": "Sulfasalazine", "alternateName": "Sulfasalazine", "url": "https://questionsmedicales.fr/mesh/D012460", "about": { "@type": "MedicalCondition", "name": "Sulfasalazine", "code": { "@type": "MedicalCode", "code": "D012460", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.730" } } }, { "@type": "MedicalWebPage", "name": "Tamsulosine", "alternateName": "Tamsulosin", "url": "https://questionsmedicales.fr/mesh/D000077409", "about": { "@type": "MedicalCondition", "name": "Tamsulosine", "code": { "@type": "MedicalCode", "code": "D000077409", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.863" } } }, { "@type": "MedicalWebPage", "name": "Xipamide", "alternateName": "Xipamide", "url": "https://questionsmedicales.fr/mesh/D014988", "about": { "@type": "MedicalCondition", "name": "Xipamide", "code": { "@type": "MedicalCode", "code": "D014988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.886.590.700.975" } } } ], "about": { "@type": "MedicalCondition", "name": "Sulfonamides", "alternateName": "Sulfonamides", "code": { "@type": "MedicalCode", "code": "D013449", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Reihane Ghomashi", "url": "https://questionsmedicales.fr/author/Reihane%20Ghomashi", "affiliation": { "@type": "Organization", "name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Shakila Ghomashi", "url": "https://questionsmedicales.fr/author/Shakila%20Ghomashi", "affiliation": { "@type": "Organization", "name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Hamidreza Aghaei", "url": "https://questionsmedicales.fr/author/Hamidreza%20Aghaei", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Ahmad Reza Massah", "url": "https://questionsmedicales.fr/author/Ahmad%20Reza%20Massah", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran." } }, { "@type": "Person", "name": "Satoru Suzuki", "url": "https://questionsmedicales.fr/author/Satoru%20Suzuki", "affiliation": { "@type": "Organization", "name": "Leading Academia in Marine and Environment Pollution Research (LaMer), Center for Marine Environmental Studies (CMES), Ehime University, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The effect of child development on the components of the Frequency Following Response: Child development and the Frequency Following Response.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36048883", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0260739" } }, { "@type": "ScholarlyArticle", "name": "Teleological Perspectives in Child and Adolescent Development.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37341671", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaac.2023.05.007" } }, { "@type": "ScholarlyArticle", "name": "Risk and resilience models in child development.", "datePublished": "2024-07-09", "url": "https://questionsmedicales.fr/article/39260902", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/bs.acdb.2024.06.005" } }, { "@type": "ScholarlyArticle", "name": "Trajectories of child growth, child development, and home child-rearing quality during the Covid pandemic in rural Nepal.", "datePublished": "2022-11-24", "url": "https://questionsmedicales.fr/article/36355606", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cch.13078" } }, { "@type": "ScholarlyArticle", "name": "Effect of parenting intervention through \"Care for Child Development Guideline\" on early child development and behaviors: a randomized controlled trial.", "datePublished": "2022-12-02", "url": "https://questionsmedicales.fr/article/36461019", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-022-03752-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Composés du soufre", "item": "https://questionsmedicales.fr/mesh/D013457" }, { "@type": "ListItem", "position": 4, "name": "Sulfones", "item": "https://questionsmedicales.fr/mesh/D013450" }, { "@type": "ListItem", "position": 5, "name": "Sulfonamides", "item": "https://questionsmedicales.fr/mesh/D013449" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sulfonamides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sulfonamides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sulfonamides", "description": "Comment diagnostiquer une infection nécessitant des sulfonamides ?\nQuels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?\nLes sulfonamides sont-ils efficaces contre toutes les bactéries ?\nQuels signes cliniques indiquent une infection bactérienne ?\nComment confirmer une infection urinaire ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Child+Development#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sulfonamides", "description": "Quels sont les symptômes d'une infection traitée par sulfonamides ?\nLes sulfonamides provoquent-ils des effets secondaires ?\nComment reconnaître une réaction allergique aux sulfonamides ?\nQuels symptômes indiquent une surinfection ?\nLes sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Child+Development#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sulfonamides", "description": "Comment prévenir les infections nécessitant des sulfonamides ?\nLes sulfonamides peuvent-ils être utilisés en prophylaxie ?\nQuelles mesures d'hygiène sont recommandées ?\nLes vaccinations aident-elles à prévenir les infections ?\nComment éviter la résistance aux antibiotiques ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Child+Development#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sulfonamides", "description": "Comment les sulfonamides sont-ils administrés ?\nQuelle est la posologie habituelle des sulfonamides ?\nLes sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?\nQuel suivi est nécessaire lors d'un traitement par sulfonamides ?\nLes sulfonamides sont-ils efficaces contre les infections virales ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Child+Development#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sulfonamides", "description": "Quelles complications peuvent survenir avec les sulfonamides ?\nComment gérer une réaction allergique sévère aux sulfonamides ?\nLes sulfonamides peuvent-ils causer des troubles rénaux ?\nQuels signes indiquent une complication grave ?\nLes sulfonamides peuvent-ils interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Child+Development#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sulfonamides", "description": "Qui est à risque de développer des effets secondaires aux sulfonamides ?\nLes personnes âgées sont-elles plus à risque avec les sulfonamides ?\nLes femmes enceintes peuvent-elles prendre des sulfonamides ?\nLes patients atteints de maladies hépatiques sont-ils à risque ?\nLes antécédents d'infections récurrentes augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=Child+Development#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection nécessitant des sulfonamides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des symptômes cliniques et des cultures bactériennes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de sensibilité aux antibiotiques sont réalisés sur des échantillons microbiologiques." } }, { "@type": "Question", "name": "Les sulfonamides sont-ils efficaces contre toutes les bactéries ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité varie selon le type de bactérie et leur résistance." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une infection bactérienne ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur, rougeur et gonflement peuvent indiquer une infection." } }, { "@type": "Question", "name": "Comment confirmer une infection urinaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un examen d'urine et une culture permettent de confirmer une infection urinaire." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection traitée par sulfonamides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur, fatigue et symptômes locaux selon l'infection." } }, { "@type": "Question", "name": "Les sulfonamides provoquent-ils des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets comme éruptions cutanées, nausées ou réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique aux sulfonamides ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Éruptions cutanées, démangeaisons, ou gonflement peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surinfection ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Augmentation de la douleur, fièvre persistante et écoulement purulent peuvent indiquer une surinfection." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nausées, vomissements ou diarrhées peuvent survenir avec leur utilisation." } }, { "@type": "Question", "name": "Comment prévenir les infections nécessitant des sulfonamides ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène, se faire vacciner et éviter les contacts avec des malades." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils être utilisés en prophylaxie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être prescrits en prophylaxie pour prévenir certaines infections." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter le partage d'objets personnels." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir les infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes." } }, { "@type": "Question", "name": "Comment éviter la résistance aux antibiotiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser les antibiotiques uniquement lorsque prescrit et suivre les recommandations médicales." } }, { "@type": "Question", "name": "Comment les sulfonamides sont-ils administrés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont généralement administrés par voie orale ou intraveineuse selon l'infection." } }, { "@type": "Question", "name": "Quelle est la posologie habituelle des sulfonamides ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie selon l'infection, mais doit être prescrite par un médecin." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être utilisés en association pour élargir le spectre d'action." } }, { "@type": "Question", "name": "Quel suivi est nécessaire lors d'un traitement par sulfonamides ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier pour surveiller les effets secondaires et l'efficacité est recommandé." } }, { "@type": "Question", "name": "Les sulfonamides sont-ils efficaces contre les infections virales ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les sulfonamides ne sont pas efficaces contre les infections virales." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les sulfonamides ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques graves, des troubles sanguins ou des lésions hépatiques peuvent survenir." } }, { "@type": "Question", "name": "Comment gérer une réaction allergique sévère aux sulfonamides ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Cesser immédiatement le traitement et consulter un médecin pour un traitement approprié." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils causer des troubles rénaux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles rénaux peuvent survenir, nécessitant une surveillance de la fonction rénale." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, éruption cutanée étendue ou difficulté respiratoire peuvent indiquer une complication." } }, { "@type": "Question", "name": "Les sulfonamides peuvent-ils interagir avec d'autres médicaments ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent interagir avec d'autres médicaments, augmentant le risque d'effets secondaires." } }, { "@type": "Question", "name": "Qui est à risque de développer des effets secondaires aux sulfonamides ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies médicamenteuses sont à risque accru." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque avec les sulfonamides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru d'effets secondaires et de complications." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles prendre des sulfonamides ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation doit être évitée, car elle peut affecter le fœtus. Consultez un médecin." } }, { "@type": "Question", "name": "Les patients atteints de maladies hépatiques sont-ils à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir un risque accru d'effets indésirables et nécessitent une surveillance." } }, { "@type": "Question", "name": "Les antécédents d'infections récurrentes augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents d'infections récurrentes peuvent nécessiter un traitement plus agressif." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 19/04/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

31 au total
└─

Bumétanide

Bumetanide D002034 - D02.886.590.700.150
└─

Diclofénamide

Dichlorphenamide D004005 - D02.886.590.700.410
└─

Mafénide

Mafenide D008272 - D02.886.590.700.570
└─

Méfruside

Mefruside D008529 - D02.886.590.700.575
└─

Probénécide

Probenecid D011339 - D02.886.590.700.625
└─

Sulfamides

Sulfanilamides D013424 - D02.886.590.700.725
└─

Sulfasalazine

Sulfasalazine D012460 - D02.886.590.700.730
└─

Tamsulosine

Tamsulosin D000077409 - D02.886.590.700.863
└─

Xipamide

Xipamide D014988 - D02.886.590.700.975
└─└─

Furosémide

Furosemide D005665 - D02.886.590.700.725.300
└─└─

Sulfacétamide

Sulfacetamide D013409 - D02.886.590.700.725.650
└─└─

Sulfachlorpyridazine

Sulfachlorpyridazine D013410 - D02.886.590.700.725.700
└─└─

Sulfadiazine

Sulfadiazine D013411 - D02.886.590.700.725.755
└─└─

Sulfadiméthoxine

Sulfadimethoxine D013412 - D02.886.590.700.725.760
└─└─

Sulfadoxine

Sulfadoxine D013413 - D02.886.590.700.725.765
└─└─

Sulfaguanidine

Sulfaguanidine D013414 - D02.886.590.700.725.810
└─└─

Sulfalène

Sulfalene D013415 - D02.886.590.700.725.850
└─└─

Sulfamérazine

Sulfamerazine D013416 - D02.886.590.700.725.853
└─└─

Sulfamétoxydiazine

Sulfameter D013417 - D02.886.590.700.725.857
└─└─

Sulfadimidine

Sulfamethazine D013418 - D02.886.590.700.725.862
└─└─

Sulfaméthoxazole

Sulfamethoxazole D013420 - D02.886.590.700.725.867
└─└─

Sulfaméthoxypyridazine

Sulfamethoxypyridazine D013421 - D02.886.590.700.725.872
└─└─

Sulfamonométhoxine

Sulfamonomethoxine D013422 - D02.886.590.700.725.877
└─└─

Sulfamoxole

Sulfamoxole D013423 - D02.886.590.700.725.882
└─└─

Sulfanilamide

Sulfanilamide D000077145 - D02.886.590.700.725.885
└─└─

Sulfapyridine

Sulfapyridine D013427 - D02.886.590.700.725.900
└─└─

Sulfaquinoxaline

Sulfaquinoxaline D013428 - D02.886.590.700.725.925
└─└─

Sulfisomidine

Sulfisomidine D013443 - D02.886.590.700.725.940
└─└─

Sulfafurazol

Sulfisoxazole D013444 - D02.886.590.700.725.945
└─└─└─

Sulfadiazine d'argent

Silver Sulfadiazine D012837 - D02.886.590.700.725.755.800
└─└─└─

Sulfaméthizol

Sulfamethizole D013419 - D02.886.590.700.725.935.813

Auteurs principaux

Reihane Ghomashi

3 publications dans cette catégorie

Affiliations :
  • Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.

Shakila Ghomashi

3 publications dans cette catégorie

Affiliations :
  • Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.

Hamidreza Aghaei

3 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.

Ahmad Reza Massah

3 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.
  • Razi Chemistry Research Center (RCRC), Shahreza Branch, Islamic Azad University, Isfahan, Iran.

Satoru Suzuki

3 publications dans cette catégorie

Affiliations :
  • Leading Academia in Marine and Environment Pollution Research (LaMer), Center for Marine Environmental Studies (CMES), Ehime University, Japan.
Publications dans "Sulfonamides" :

David A Khan

2 publications dans cette catégorie

Affiliations :
  • Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Publications dans "Sulfonamides" :

Ligui Wu

2 publications dans cette catégorie

Affiliations :
  • College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China; School of Life Science, Jinggangshan University, Ji'an 343009, China.

Lingling Rong

2 publications dans cette catégorie

Affiliations :
  • School of Life Science, Jinggangshan University, Ji'an 343009, China.

Xiaoming Zou

2 publications dans cette catégorie

Affiliations :
  • School of Life Science, Jinggangshan University, Ji'an 343009, China. Electronic address: zouxming_80@hotmail.com.

Jun Chen

2 publications dans cette catégorie

Affiliations :
  • Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Publications dans "Sulfonamides" :

Andrea Angeli

2 publications dans cette catégorie

Affiliations :
  • Section of Pharmaceutical and Nutraceutical Sciences, Department of Neurofarba, University of Florence, Via U. Schiff 6, 50019 Sesto Fiorentino (Florence), Italy.
Publications dans "Sulfonamides" :

Fabrizio Carta

2 publications dans cette catégorie

Affiliations :
  • Section of Pharmaceutical and Nutraceutical Sciences, Department of Neurofarba, University of Florence, Via U. Schiff 6, 50019 Sesto Fiorentino (Florence), Italy.
Publications dans "Sulfonamides" :

Claudiu T Supuran

2 publications dans cette catégorie

Affiliations :
  • Section of Pharmaceutical and Nutraceutical Sciences, Department of Neurofarba, University of Florence, Via U. Schiff 6, 50019 Sesto Fiorentino (Florence), Italy.
Publications dans "Sulfonamides" :

Clemente Capasso

2 publications dans cette catégorie

Affiliations :
  • Institute of Biosciences and Bioresources, CNR, Via Pietro Castellino 111, 80131 Napoli, Italy.
Publications dans "Sulfonamides" :

Weijuan Yang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Ecological Pest Control for Fujian and Taiwan Crops, College of Plant Protection, Fujian Agriculture and Forestry University, Fuzhou 350002, China.

FengFu Fu

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory for Analytical Science of Food Safety and Biology of MOE, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China.

Takayoshi Awakawa

2 publications dans cette catégorie

Affiliations :
  • Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan.
Publications dans "Sulfonamides" :

Ikuro Abe

2 publications dans cette catégorie

Affiliations :
  • Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan.
Publications dans "Sulfonamides" :

Aya Kadoya

2 publications dans cette catégorie

Affiliations :
  • Center for Marine Environmental Studies, Ehime University, Matsuyama, Ehime, 790-8577, Japan.
Publications dans "Sulfonamides" :

Patrick L Purder

1 publication dans cette catégorie

Affiliations :
  • Department of Organic Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt, Alarich-Weiss-Straße 4, 64287 Darmstadt, Germany.
Publications dans "Sulfonamides" :

Sources (10000 au total)

The effect of child development on the components of the Frequency Following Response: Child development and the Frequency Following Response.

During childhood, neuronal modifications occur so that typical childhood communicative development occurs. This work aims to contribute to the understanding of differences in the speech encoding of in...

Trajectories of child growth, child development, and home child-rearing quality during the Covid pandemic in rural Nepal.

Children, especially disadvantaged children in poor countries, were expected to be among the "biggest victims" of the Covid pandemic. Economic burdens, decreased nutritious foods, reduced medical care... A planned nutrition intervention could not be implemented due to Covid restrictions. However, three surveys (pre-Covid [December 2019], July 2021, and September 2021) in 280 Nepali households (309 par... Height, mid-upper-arm circumference, and head circumference measurements improved over time. The total ASQ-3 score did not change: Communication scores increased while fine motor and personal-social s... In this sample, some aspects of child growth, development, and home child-rearing quality improved while others declined. Better understanding of these changes in child well-being and the family envir...

Effect of parenting intervention through "Care for Child Development Guideline" on early child development and behaviors: a randomized controlled trial.

Several studies showed that parenting intervention programs play a core component in early child development. Considering the limited healthcare resources in developing countries, group-session interv... This randomized controlled trial was conducted at an outpatient public Pediatrics clinic in Isfahan, Iran. We included 210 pregnant women aged 18-45 years in their third trimester and followed their c... Overall, data of 181 children were included in the current study, including 80 in the intervention group and 101 controls. The adjusted median/mean differences between intervention and control groups ... In this study, parenting interventions through CCD group sessions were significantly effective on just one subscale of children's socio-emotional behavior domains based on CBCL and one domain of child... IRCT20190128042533N2, Date of registration: 16/01/2020, www.irct.ir....

A biopsychosocial model of NICU family adjustment and child development.

Although infants in Neonatal Intensive Care Units (NICU) are at risk for developmental impairments and parents are at risk for emotional distress, factors that explain outcomes remain unknown. Here, w... Participants included 101 families at The Children's Hospital of Philadelphia Neonatal Follow-Up Program who had been discharged 1.5-2.5 years prior. We gathered data using validated assessments, stan... Our structural equation model, informed by the Double ABC-X Model, captured the dynamic relationships among infant, parent, couple, and family factors. Infant medical severity, posttraumatic stress, c... Interventions that target parental posttraumatic stress, couple dynamics, parental perception of time for themselves, and access to financial support could be key for improving NICU family outcomes....

The impact of agricultural disasters on child development in rural China.

China's uneven development under the urban-rural dichotomy has led to the discouraging development of children in rural areas. China is a large agricultural country and agricultural disasters are rela... This study explored the effects of agricultural disasters on rural children's development, including cognitive and noncognitive skills, and academic pressure.... Survey data from the China Family Panel Survey and the National Meteorological Administration for 2010-2018 and a fixed-effect panel model with difference-in-differences regressions were used in the s... The fixed effects model results showed evidence that agricultural disasters have a negative impact on rural children's cognitive and noncognitive skills and a positive impact on academic pressure. The... Evidence shows that agricultural disasters have a significant negative impact on rural child development. It may be inferred that these will increase the difficulty of narrowing the urban-rural develo...

Interactive technology use and child development: A systematic review.

There is mixed evidence regarding the impact of interactive digital devices on child development. Tentatively some studies suggested that the use of digital devices may correlate negatively with langu... To carry out this systematic review, databases CINAHL, MEDLINE, Embase, PsychINFO, Scopus and Google Scholar were searched for relevant studies.... We used the Joanna Briggs Institute methodology for systematic reviews.... Data extraction and synthesis was carried out by two reviewers and checked by a third reviewer. Studies were stratified into tiers depending on the level of evidence provided and the domain of develop... Fifty-three studies were eligible for inclusion in the review, 39 Tier 1 (randomized controlled trials and quasi-experimental studies) and 16 Tier 2 (descriptive studies). Children's use of interactiv... The studies included in this review were predominantly correlational or comparative in nature and focuses on cognitive domains of learning rather than a specific developmental outcome. It is difficult...

Men's perception of paternal parenthood and the promotion of child development.

to comprehend men's perception of paternal parenthood while caring for infants to promote child development.... this qualitative study adopts an exploratory approach and was conducted with undergraduate and graduate students, faculty, and staff who are fathers of infants up to 6 months old from a higher educati... fifteen men participated in the study. From the analysis, two empirical categories emerged: "Perception of being a father: challenges and novelties" and "Promotion of child development: actions carrie... the relevance of the paternal figure for child development is highlighted, as well as the need for public policies to encourage paternal parenthood....